Quick Answer
Camp4 Therapeutics Corp reported Stockholders Equity of $47.70 million for the year ending 2025.
- Camp4 Therapeutics Corp showed a decrease of -24.5% in Stockholders Equity from 2024 to 2025.
- This data is from Camp4 Therapeutics Corp's annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2023: -$89.27 million | Q2 2023: -$100.58 million | Q3 2023: -$111.55 million | Q1 2024: -$135.33 million | Q2 2024: -$147.11 million | Q3 2024: -$158.98 million | Q1 2025: $51.57 million | Q2 2025: $39.99 million | Q3 2025: $58.67 million.
- Over the full 4 years of available data (2022 to 2025), Camp4 Therapeutics Corp's Stockholders Equity has grown by 161.5%.
- Historical annual values: Fiscal year 2025: $47.70 million | Fiscal year 2024: $63.14 million | Fiscal year 2023: -$123.73 million | Fiscal year 2022: -$77.53 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: